Ifomide/pirarubicin/etoposide/carboplatin (ITEC) as second-line chemotherapy for hepatoblastoma.

Eiso Hiyama,Arata Kamimatsuse,Kaoru Ogura,Tomoro Hishiki,Kenichiro Watanabe,Michihiro Yano,Satoshi Kondo,Tatsuro Tajiri,Kohmei Ida,Fumiaki Sasaki

Ifomide/pirarubicin/etoposide/carboplatin (ITEC) as second-line chemotherapy for hepatoblastoma.

2017

Eiso Hiyama
Arata Kamimatsuse
Kaoru Ogura
Tomoro Hishiki
Kenichiro Watanabe
Michihiro Yano
Satoshi Kondo
Tatsuro Tajiri
Kohmei Ida
Fumiaki Sasaki

9577 Background: The Japanese Study Group for Pediatric Liver Tumor is running cooperative treatment studies on hepatoblastoma (HBL) since 1991. The main aim in JPLT-1 study was to evaluate the eff...

Keywords:

Pathology
Etoposide carboplatin
Pirarubicin
Medicine
Oncology
Chemotherapy
Hepatoblastoma
Internal medicine
Liver tumor
treatment study
second line chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations